Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gynecology
»
Breast Diseases
15. November 2026
Search
medline.ch
Breast Diseases
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Reproduction
Genital Diseases female
Infertility
Breast Diseases
Menopause
Pregnancy
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 11212
Articles 1 - 20 / 224233
Acupuncture for cancer-related fatigue in breast cancer survivors: the AcuBreast study, a pragmatic randomized clinical trial.
Integr Med Res
Alræk T, Skjerve H, Sørensen A, Mao JJ, Lamu AN, Lu W, Deng G, Lee MS, Birch S, Kim TH, Lie SA.
PMID: 43034755 [PubMed]
Burden and Temporal Trends of Female Breast Cancer Attributable to High Fasting Plasma Glucose in China and G20 Countries, 1990-2023: An Analysis of the Global Burden of Disease Study 2023.
Int J Womens Health
Zheng J, Ye Z, Chen S, Lin W, Chen W, Li H, Kuang Z, Wu X.
PMID: 43034638 [PubMed]
Dapagliflozin transfer in breast milk may be clinically insignificant-An opportunity for optimization of evidence-based management of heart failure in postpartum patients.
Pregnancy (Hoboken)
Bartell A, Erickson J, Anderson LJ, Boitos L, Katzman HR, Mohamed M, Dwyer S, Tumbarello J, Kirschen GW, Langen E, Grabowski A, Gregg B.
PMID: 43034521 [PubMed]
Co-conditioning and parallel cell homing-driven pre-metastatic niche engineering: TGF-β-fuelled 3D microphysiological model for epithelial-mesenchymal transition in breast cancer.
In Vitro Model
Vaishnavi M, Kumari M, Pal S, Kaur K, Kaity S, Mandal C, Roy S.
PMID: 43034390 [PubMed]
Impact of Lifestyle Behaviors and Social Determinants of Health on Breast Cancer Prevention and Survivorship: A Comprehensive Primary Analysis of Patient-Reported Data.
Am J Lifestyle Med
Ayers KE, Mussallem D, Petrov JC, Pedersen L.
PMID: 43034359 [PubMed - as supplied by publisher]
Eligible Studies Omitted From the Meta-Analysis on Contrast-Enhanced Mammography for Breast Asymmetries.
Acad Radiol
Barra FR.
PMID: 43034114 [PubMed - as supplied by publisher]
Weight-Adjusted Waist Index and Breast Cancer Prevalence in U.S. Adult Women: A Cross-Sectional NHANES Analysis (1999-2016).
Cancer Med
Li Y, Yang Z, An Y, Yu Y, Cao X, Wang X.
PMID: 43034091 [PubMed - indexed for MEDLINE]
Determinants of participation in organized breast, cervical and colorectal cancer screening in Europe: A scoping review.
Health Policy
Marasciulo D, Mercuri C, Simeone S, Doldo P.
PMID: 43033790 [PubMed - as supplied by publisher]
Collagen and CXCL10 expression as key components of the structural and inflammatory dimensions of the tumor microenvironment in breast cancer subtypes.
Acta Histochem
Nakano LKM, Moreira TB, Pereira RA, Mesquita FAS, Teixeira-Carvalho A, Salles PGO, Portella MAM, Amorim IFG, Braga LDC.
PMID: 43033750 [PubMed - as supplied by publisher]
Pregnancy after breast cancer and risk of recurrence. A risk-set-matched cohort study with a time-dependent analysis.
Cancer Epidemiol
Bonyadi M, Hosseinpour Z, Akbari A, Akbari ME.
PMID: 43033674 [PubMed - as supplied by publisher]
Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE).
Breast
Ozaki Y, Taniguchi E, Nozawa K, Niwa Y, Hara F, Nonogaki K, Kuno M, Aoyama Y, Inagaki L, Masuda J, Nishimura M, Kurata M, Hosonaga M, Fukada I, Kimura Y, Maeda T, Yoshida K, Yamashita N, Kobayashi T, Takano T, Ueno T.
PMID: 43033562 [PubMed - as supplied by publisher]
Updated results from ASCENT-J02, a study of sacituzumab govitecan in Japanese participants with metastatic triple-negative breast cancer.
Int J Clin Oncol
Kawaguchi-Sakita N, Naito Y, Ishida T, Nakayama T, Yamamoto Y, Masuda N, Matsumoto K, Kogawa T, Sudo K, Shimomura A, Lai C, Shao J, Iwahori Y, Gary D, Huynh D, Iwata H.
PMID: 43033364 [PubMed - as supplied by publisher]
Screening for rehabilitation needs in newly diagnosed breast cancer patients: exploring psychometric properties of the National Comprehensive Cancer Network(®) (NCCN(®)) Distress Thermometer and Problem List.
J Patient Rep Outcomes
Velickovic K, Bendahl PO, Olsson Möller U, Rydén L, Malmström M.
PMID: 43033328 [PubMed - indexed for MEDLINE]
Rechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors.
Breast Cancer Res Treat
Petrelli F, Ghidini A, Parati MC, Ghilardi M, Borgonovo K, Dottorini L.
PMID: 43033310 [PubMed - indexed for MEDLINE]
Association between screen-detected health-related social needs and nonadherence to endocrine therapy in patients with nonmetastatic breast cancer: an observational study.
Breast Cancer Res Treat
Liyanage-Don N, DeStephano D, Sathe C, Lee S, Beauchemin M, Accordino M, Hershman D, Kronish IM.
PMID: 43033306 [PubMed - indexed for MEDLINE]
Survival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.
Breast Cancer Res Treat
Wu Y, Kong L, Oghenefejiro EE, Cao X, Wang D, Tao C, Wang X, Qin R, Ji Y, Yin L.
PMID: 43033282 [PubMed - indexed for MEDLINE]
Changes in functional capacity, flexibility and depressive symptoms in women with breast cancer submitted to adjuvant radiotherapy: randomized controlled clinical trial with mat pilates.
Support Care Cancer
Torres DM, de Menezes Fireman K, Fabro EAN, Thuler LCS, Bergmann A, da Silva Santos S.
PMID: 43033270 [PubMed - indexed for MEDLINE]
Cardiac substructure dose in thoracic VMAT without explicit constraints: FMO versus SPO on uRT-TPOIS with cross-platform reference to eclipse PO.
J Appl Clin Med Phys
Wu C, Cao Z, Duan T, Han L, Wang B, Lei W.
PMID: 43033214 [PubMed - indexed for MEDLINE]
Survival Differences Between De Novo and Recurrent HER2-Positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.
Oncology
Komatsu T, Osawa H, Cronin K, Okazawa K, Suzuki T, Tiersten A.
PMID: 43033143 [PubMed - as supplied by publisher]
CRISPR-AsCas12a with crRNA-Free Collateral Cleavage Activity for Electrochemical Diagnosis of HER2-Positive Breast Cancer.
ACS Sens
Wu S, Xu J, Sun Y, Zeng T, Li Z, Zhou T, Deng Y, Ye C, Li G, Yin Y.
PMID: 43033087 [PubMed - as supplied by publisher]
Articles 1 - 20 / 224233
Page 1 of 11212
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy